Elsa P.
- Country
- Italy
- Department
- Hematology
Research Overview
- Phase II Study of Pirtobrutinib as Frontline Therapy in Elderly Unfit or Frail Patients with Mantle Cell Lymphoma
- Phase II Multicenter Study of Glofitamab Combination Therapy in Relapsed/Refractory Mantle Cell Lymphoma After CAR‑T Cell Failure
- Phase III Double-Blind, Randomized, Placebo-Controlled Study of Human Normal Immunoglobulin for Infection Prophylaxis in Chronic Lymphocytic Leukemia with Secondary Immunodeficiency
Data & Insights
Has run more than one trial at 64 of 200 partner sites.
Specializations
Lymphoma Research
This investigator specializes in treating various forms of B-cell lymphomas, with particular focus on Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma. Their research encompasses innovative treatment approaches for elderly patients and those with high tumor burden.
- Advanced stage follicular lymphoma management
- B-cell lymphoma immunotherapy
- Primary CNS lymphoma treatment
The investigator explores optimized immunochemotherapy protocols and targeted therapeutic strategies.
Leukemia Studies
The investigator conducts research in chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL), focusing on infection prevention and chemotherapy-free alternatives.
- Secondary immunodeficiency management
- Chemotherapy-free treatment approaches
- Front-line therapy optimization
Their work includes evaluation of novel therapeutic combinations and preventive strategies for immunocompromised patients.
Innovative Therapies
The investigator evaluates targeted therapeutic approaches and immunotherapy combinations, including research into novel drug combinations and treatment optimization strategies.
- Combination immunotherapy protocols
- Treatment duration optimization
- Maintenance therapy strategies
Their research includes assessment of modified treatment durations and intensities for various hematologic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.